Details for Switzerland Supplementary Protection Certificate: C02504364/01
Switzerland Supplementary Protection Certificate: C02504364/01
| Country | Patent Number | Supplementary Protection Certificate | SPC Country | SPC Description | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2504364 | C02504364/01 | Switzerland | PRODUCT NAME: DURVALUMAB; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 66548 11.06.2018 | ⤷ Start Trial |
| >Country | >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Description | >SPC Expiration |
